Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
11.07
+0.33 (3.07%)
At close: Feb 21, 2025, 4:00 PM
11.20
+0.13 (1.17%)
After-hours: Feb 21, 2025, 7:45 PM EST
Arcus Biosciences Employees
Arcus Biosciences had 577 employees as of December 31, 2023. The number of employees increased by 77 or 15.40% compared to the previous year.
Employees
577
Change (1Y)
77
Growth (1Y)
15.40%
Revenue / Employee
$455,806
Profits / Employee
-$467,938
Market Cap
1.01B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
RCUS News
- 4 days ago - Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering - Business Wire
- 4 days ago - Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock - Business Wire
- 7 days ago - New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer - Business Wire
- 11 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 12 days ago - Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium - Business Wire
- 4 weeks ago - Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer - Business Wire
- 5 weeks ago - Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 - Seeking Alpha
- 5 weeks ago - Arcus: Excellent Pipeline And Collaborations, Cash Runway - Seeking Alpha